This map demonstrates the breadth of HIV prevention research and demonstration projects in Uganda by site and type (e.g. daily oral PrEP, preventive Vaccines, etc.). This map was developed by Wits RHI with support from AVAC as part of the Coalition to Accelerate and Support Prevention Research.
Map of HIV Prevention Research and PrEP Demonstration Sites in Uganda
Map of HIV Prevention Research and PrEP Demonstration Sites in Zambia
This map demonstrates the breadth of HIV prevention research and demonstration projects in Zambia by site and type (e.g. daily oral PrEP, preventive Vaccines, etc.). This map was developed by Wits RHI with support from AVAC as part of the Coalition to Accelerate and Support Prevention Research.
Map of HIV Prevention Research and PrEP Demonstration Sites in Zimbabwe
This map demonstrates the breadth of HIV prevention research and demonstration projects in Zimbabwe by site and type (e.g. daily oral PrEP, preventive Vaccines, etc.). This map was developed by Wits RHI with support from AVAC as part of the Coalition to Accelerate and Support Prevention Research.
HIV Vaccine Science, Research, Updates and Advocacy
With HIV Vaccine Awareness Day (HVAD) in the spotlight earlier this month, AVAC’s May episode of PxPulse features four experts steeped in HIV vaccine research. Together they help set expectations for where the field is now and where it is going.
The Stories of HIV Vaccines in 2018—From science to stakeholder engagement
This four-pager explores stories about stakeholder engagement in the current suite of efficacy trials as well as stories around global support for vaccine research in the age of an expanded HIV prevention landscape.
Vaccines Efficacy Trials: A surge of activity
A picture of the status of vaccine trials since 2003: The four trials shown here represent an unprecedented number of late phase trials underway in vaccines research.
Prevention Research & Oral PrEP Rollout: The evolving context for HIV prevention research
Many of the current or planned prevention trials are taking place in countries where daily oral PrEP is available or will be soon. This infographic shows the status PrEP and the location of scheduled trials by country.
Vaccine and Antibody Trial Participant Recruitment, 2018
A global snapshot of total numbers of participants in trials by country.
Px Wire April-June 2018, Vol. 11, No. 2
In the new issue of Px Wire, AVAC gives our take on this year’s PEPFAR process for establishing the Country Operational Plans (COPs). These plans define what work will be done with PEPFAR money at the country level and how that work will be evaluated in each of the 63 countries that receive PEPFAR money.
Interpreting PEPFAR Data: A look at Zimbabwe
In this centerspread taken from Px Wire, our quarterly newsletter, we take a closer look at Zimbabwe’s data, and highlights amfAR’s detailed country factsheets that draw from PEPFAR’s giant data sets. Additional tools and information on influencing the COPs process are available from COMPASS partner Health GAP’s PEPFAR Watch.